{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:15:45Z","timestamp":1794701745924,"version":"4.9.1"},"reference-count":89,"publisher":"Oxford University Press (OUP)","issue":"Supplement_4","license":[{"start":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T00:00:00Z","timestamp":1696377600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","award":["75D30119C06056"],"award-info":[{"award-number":["75D30119C06056"]}],"id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001453","name":"American Brain Tumor Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The Central Brain Tumor Registry of the United States (CBTRUS), in collaboration with the Centers for Disease Control and Prevention and the National Cancer Institute, is the largest population-based registry focused exclusively on primary brain and other central nervous system (CNS) tumors in the United States (US) and represents the entire US population. This report contains the most up-to-date population-based data on primary brain tumors available and supersedes all previous CBTRUS reports in terms of completeness and accuracy. All rates are age-adjusted using the 2000 US standard population and presented per 100,000 population. The average annual age-adjusted incidence rate (AAAIR) of all malignant and non-malignant brain and other CNS tumors was 24.83 per 100,000 population (malignant AAAIR=6.94 and non-malignant AAAIR=17.88). This overall rate was higher in females compared to males (27.85 versus 21.62 per 100,000) and non-Hispanic persons compared to Hispanic persons (25.24 versus 22.61 per 100,000). Gliomas accounted for 26.3% of all tumors. The most commonly occurring malignant brain and other CNS histopathology was glioblastoma (14.2% of all tumors and 50.9% of all malignant tumors), and the most common predominantly non-malignant histopathology was meningioma (40.8% of all tumors and 56.2% of all non-malignant tumors). Glioblastomas were more common in males, and meningiomas were more common in females. In children and adolescents (ages 0-19 years), the incidence rate of all primary brain and other CNS tumors was 6.13 per 100,000 population. There were 86,030 deaths attributed to malignant brain and other CNS tumors between 2016 and 2020. This represents an average annual mortality rate of 4.42 per 100,000 population and an average of 17,206 deaths per year. The five-year relative survival rate following diagnosis of a malignant brain and other CNS tumor was 35.7%, for a non-malignant brain and other CNS tumor the five-year relative survival rate was 91.8%.<\/jats:p>","DOI":"10.1093\/neuonc\/noad149","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T15:49:13Z","timestamp":1696434553000},"page":"iv1-iv99","source":"Crossref","is-referenced-by-count":1145,"title":["CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016\u20142020"],"prefix":"10.1093","volume":"25","author":[{"given":"Quinn T","family":"Ostrom","sequence":"first","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL , USA"},{"name":"Department of Neurosurgery, Duke University School of Medicine , Durham, NC , USA"},{"name":"The Preston Robert Tisch Brain Tumor Center, Duke University School of Medicine , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mackenzie","family":"Price","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL , USA"},{"name":"Department of Neurosurgery, Duke University School of Medicine , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"Neff","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL , USA"},{"name":"Department of Neurosurgery, Duke University School of Medicine , Durham, NC , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gino","family":"Cioffi","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL , USA"},{"name":"Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin A","family":"Waite","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL , USA"},{"name":"Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Kruchko","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill S","family":"Barnholtz-Sloan","sequence":"additional","affiliation":[{"name":"Central Brain Tumor Registry of the United States , Hinsdale, IL , USA"},{"name":"Trans Divisional Research Program (TDRP), Division of Cancer Epidemiology and Genetics (DCEG), National Cancer Institute , Bethesda, MD , USA"},{"name":"Center for Biomedical Informatics & Information Technology (CBIIT), National Cancer Institute , Bethesda, MD , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,10,4]]},"reference":[{"issue":"3","key":"2023100419475443800_CIT0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/neuonc\/noy006","article-title":"The CBTRUS story: providing accurate population-based statistics on brain and other central nervous system tumors for everyone","volume":"20","author":"Kruchko","year":"2018","journal-title":"Neuro Oncol"},{"key":"2023100419475443800_CIT0002","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2016"},{"issue":"4","key":"2023100419475443800_CIT0003","first-page":"317","article-title":"Aligning the Central Brain Tumor Registry of the United States (CBTRUS) histology groupings with current definitions","volume":"9","author":"Waite","year":"2022","journal-title":"Neurooncol. Pract"},{"key":"2023100419475443800_CIT0004","author":"Centers for Disease Control and Prevention (CDC)","year":"1999"},{"key":"2023100419475443800_CIT0005"},{"key":"2023100419475443800_CIT0006"},{"key":"2023100419475443800_CIT0007","author":"National Cancer Institute"},{"key":"2023100419475443800_CIT0008","volume-title":"National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database: U.S. Cancer Statistics Incidence Analytic Database \u2013 2001-2020","author":"Centers for Disease Control and Prevention National Center for Health Statistics","year":"2023"},{"issue":"11","key":"2023100419475443800_CIT0009","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1093\/neuonc\/nos208","article-title":"Ionizing radiation and the risk of brain and central nervous system tumors: a systematic review","volume":"14","author":"Braganza","year":"2012","journal-title":"Neuro. Oncol"},{"issue":"2","key":"2023100419475443800_CIT0010","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1158\/1055-9965.EPI-15-0847","article-title":"Approaching a Scientific Consensus on the Association between Allergies and Glioma Risk: A Report from the Glioma International Case-Control Study","volume":"25","author":"Amirian","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"2023100419475443800_CIT0011","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/ijc.11213","article-title":"Familial brain tumours\u2014genetics or environment? A nationwide cohort study of cancer risk in spouses and first-degree relatives of brain tumour patients","volume":"106","author":"Malmer","year":"2003","journal-title":"Int. J. Cancer"},{"issue":"7","key":"2023100419475443800_CIT0012","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/oxfordjournals.aje.a009154","article-title":"Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls","volume":"145","author":"Wrensch","year":"1997","journal-title":"Am. J. Epidemiol"},{"issue":"3","key":"2023100419475443800_CIT0013","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/(SICI)1097-0215(19990505)81:3<366::AID-IJC9>3.0.CO;2-0","article-title":"Familial aggregation of astrocytoma in northern Sweden: An epidemiological cohort study","volume":"81","author":"Malmer","year":"1999","journal-title":"Int. J. Cancer"},{"issue":"12","key":"2023100419475443800_CIT0014","first-page":"1443","article-title":"Cancer in first-degree relatives and risk of glioma in adults","volume":"12","author":"Hill","year":"2003","journal-title":"Cancer Epidemiol. Biomarkers Prev"},{"issue":"11","key":"2023100419475443800_CIT0015","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1158\/1055-9965.EPI-07-0576","article-title":"Aggregation of cancer in first-degree relatives of patients with glioma","volume":"16","author":"Scheurer","year":"2007","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"2023100419475443800_CIT0016","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.3171\/2011.6.JNS11129","article-title":"Family and personal medical history and risk of meningioma","volume":"115","author":"Claus","year":"2011","journal-title":"J. Neurosurg"},{"issue":"7","key":"2023100419475443800_CIT0017","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/neuonc\/nou087","article-title":"The epidemiology of glioma in adults: a \u201cstate of the science\u201d review","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"issue":"12","key":"2023100419475443800_CIT0018","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1158\/1055-9965.EPI-14-0207","article-title":"Childhood brain tumor epidemiology: a brain tumor epidemiology consortium review","volume":"23","author":"Johnson","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"3","key":"2023100419475443800_CIT0019","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-010-0386-3","article-title":"Epidemiology and etiology of meningioma","volume":"99","author":"Wiemels","year":"2010","journal-title":"J. Neurooncol"},{"key":"2023100419475443800_CIT0020","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noz123","article-title":"Risk Factors For Childhood And Adult Primary Brain Tumors","author":"Ostrom","year":"2019","journal-title":"Neuro. Oncol"},{"key":"2023100419475443800_CIT0021","volume-title":"International Classification of Diseases for Oncology","author":"Fritz","year":"2000"},{"key":"2023100419475443800_CIT0022","volume-title":"SEER*Stat Database: Mortality - All COD, Aggregated With State, Total U.S. (1969-2020) &lt;Katrina\/Rita Population Adjustment&gt;","author":"Surveillance Epidemiology and End Results (SEER) Program"},{"key":"2023100419475443800_CIT0023","author":"Surveillance Research Program - National Cancer Institute","year":"2022"},{"issue":"2","key":"2023100419475443800_CIT0024","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1215\/15228517-4-2-134","article-title":"Consensus Conference on Brain Tumor Definition for registration. November 10, 2000","volume":"4","author":"McCarthy","year":"2000","journal-title":"Neuro Oncol"},{"key":"2023100419475443800_CIT0025","author":"Surveillance Epidemiology aERSP","year":"2017"},{"key":"2023100419475443800_CIT0026","volume-title":"International Incidence of Childhood Cancer, Volume III.","year":"2017"},{"issue":"7","key":"2023100419475443800_CIT0027","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1002\/cncr.20910","article-title":"International Classification of Childhood Cancer, third edition","volume":"103","author":"Steliarova-Foucher","year":"2005","journal-title":"Cancer"},{"key":"2023100419475443800_CIT0028","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues, Fourth Edition","author":"Swerdlow","year":"2007"},{"issue":"1","key":"2023100419475443800_CIT0029","first-page":"vdaa175","article-title":"An updated histology recode for the analysis of primary malignant and nonmalignant brain and other central nervous system tumors in the Surveillance, Epidemiology, and End Results Program","volume":"3","author":"Forjaz","year":"2021","journal-title":"Neurooncol Adv"},{"issue":"4","key":"2023100419475443800_CIT0030","article-title":"The Central Brain Tumor Registry of the United States Histopathological Grouping Scheme Provides Clinically Relevant Brain and other Central Nervous System Categories for Cancer Registry Data","volume":"49","author":"Ostrom","year":"2022","journal-title":"J. Registry. Manag"},{"issue":"1","key":"2023100419475443800_CIT0031","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11060-016-2217-7","article-title":"Completeness of required site-specific factors for brain and CNS tumors in the Surveillance, Epidemiology and End Results (SEER) 18 database (2004-2012, varying)","volume":"130","author":"Ostrom","year":"2016","journal-title":"J. Neurooncol"},{"issue":"11","key":"2023100419475443800_CIT0032","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1093\/neuonc\/noac113","article-title":"Molecular biomarker-defined brain tumors: Epidemiology, validity, and completeness in the United States","volume":"24","author":"Iorgulescu","year":"2022","journal-title":"Neuro Oncol"},{"key":"2023100419475443800_CIT0033","volume-title":"Tumours of the nervous system: World Health Organization classification of tumours.","author":"Kleihues","year":"2000"},{"key":"2023100419475443800_CIT0034","volume-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007"},{"key":"2023100419475443800_CIT0035","author":"American Joint Committee on Cancer","year":"2020"},{"issue":"1","key":"2023100419475443800_CIT0036","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11060-015-1775-4","article-title":"Completeness and concordancy of WHO grade assignment for brain and central nervous system tumors in the United States, 2004-2011","volume":"123","author":"Lym","year":"2015","journal-title":"J. Neurooncol"},{"key":"2023100419475443800_CIT0037","doi-asserted-by":"crossref","first-page":"iv1","DOI":"10.1093\/neuonc\/nou223","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011","volume":"16","author":"Ostrom","year":"2014","journal-title":"Neuro Oncol"},{"key":"2023100419475443800_CIT0038","article-title":"Histological groups","volume-title":"Cancer Incidence in Five Continents Volume XI","author":"Ferlay","year":"2019"},{"key":"2023100419475443800_CIT0039","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2019"},{"issue":"2","key":"2023100419475443800_CIT0040","first-page":"298","article-title":"Pilocytic astrocytomas: where do they belong in cancer reporting","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro Oncol"},{"key":"2023100419475443800_CIT0041","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noac161","article-title":"CBTRUS Statistical Report: Pediatric Brain Tumor Foundation Childhood and Adolescent Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States 2014-2018","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol"},{"key":"2023100419475443800_CIT0042","volume-title":"CDC National Program of Cancer Registries and NCI Surveillance, Epidemiology and End Results Incidence Data, 2022 submission (2000\u20132020)","author":"Central Brain Tumor Registry of the United States SEER*Stat Database","year":"2023"},{"key":"2023100419475443800_CIT0043","first-page":"547","article-title":"Efficient interval estimation for age-adjusted cancer rates","volume-title":"Stat. Methods Med. Res","author":"Tiwari","year":"2006"},{"key":"2023100419475443800_CIT0044","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2020"},{"key":"2023100419475443800_CIT0045","volume-title":"Joinpoint Regression Program, Version 5.0.2.0; Statistical Methodology and Applications Branch, Surveillance Research Program","year":"2023"},{"key":"2023100419475443800_CIT0046","volume-title":"prevEst (version 2.0)","author":"Neff","year":"2022"},{"key":"2023100419475443800_CIT0047","volume-title":"SEER*Stat Database: Incidence - SEER Research Plus Data, 8 Registries, Nov 2021 Sub (1975-2019) - Linked To County Attributes - Total U.S., 1969-2020 Counties","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2022"},{"key":"2023100419475443800_CIT0048","volume-title":"CDC National Program of Cancer Registries and NCI Surveillance, Epidemiology and End Results Incidence Data, 2021 submission (2000\u20132019)","author":"Central Brain Tumor Registry of the United States SEER*Stat Database","year":"2022"},{"key":"2023100419475443800_CIT0049","author":"NAACCR Race and Ethnicity Work Group","year":"2012"},{"key":"2023100419475443800_CIT0050","author":"R Core Team","year":"2022"},{"key":"2023100419475443800_CIT0051","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2022"},{"key":"2023100419475443800_CIT0052","author":"Luo","year":"2012"},{"key":"2023100419475443800_CIT0053","author":"Gohel","year":"2020"},{"key":"2023100419475443800_CIT0054","author":"Gohel","year":"2020"},{"issue":"10","key":"2023100419475443800_CIT0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.18637\/jss.v071.i10","article-title":"Computation of Graphlet Orbits for Nodes and Edges in Sparse Graphs","volume":"71","author":"Ho\u010devar","year":"2016","journal-title":"J. Stat. Softw"},{"key":"2023100419475443800_CIT0056","article-title":"Welcome to the Tidyverse","volume":"1686","author":"Wickham","year":"2019","journal-title":"Journal of Open Source Software"},{"key":"2023100419475443800_CIT0057","author":"Sievert","year":"2020"},{"key":"2023100419475443800_CIT0058","author":"Xie","year":"2020"},{"key":"2023100419475443800_CIT0059","author":"Walker","year":"2020"},{"key":"2023100419475443800_CIT0060","author":"Kassambara","year":"2020"},{"key":"2023100419475443800_CIT0061","doi-asserted-by":"crossref","first-page":"439","DOI":"10.32614\/RJ-2018-009","article-title":"Simple Features for R: Standardized Support for Spatial Vector Data","author":"Pebesma","year":"2018","journal-title":"The R Journal"},{"issue":"469","key":"2023100419475443800_CIT0062","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1198\/016214504000001899","article-title":"Modeling Reporting Delays and Reporting Corrections in Cancer Registry Data","volume":"100","author":"Midthune","year":"2005","journal-title":"J. Am. Stat. Assoc"},{"issue":"Suppl 5","key":"2023100419475443800_CIT0063","first-page":"1","article-title":"CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2015-2019","volume":"24","author":"Ostrom","year":"2022","journal-title":"Neuro Oncol"},{"key":"2023100419475443800_CIT0064","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.34837","article-title":"Complete prevalence of primary malignant and non-malignant brain tumors in comparison to other cancers in the United States","author":"Neff","year":"2023","journal-title":"Cancer"},{"issue":"1","key":"2023100419475443800_CIT0065","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3322\/caac.21763","article-title":"Cancer statistics, 2023","volume":"73","author":"Siegel","year":"2023","journal-title":"CA Cancer J. Clin"},{"issue":"4","key":"2023100419475443800_CIT0066","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1093\/neuonc\/noy002","article-title":"Females have the survival advantage in glioblastoma","volume":"20","author":"Ostrom","year":"2018","journal-title":"Neuro Oncol"},{"issue":"9","key":"2023100419475443800_CIT0067","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult Glioma Incidence and Survival by Race or Ethnicity in the United States From 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol"},{"issue":"6","key":"2023100419475443800_CIT0068","first-page":"451","article-title":"Sex is an important prognostic factor for glioblastoma but not for nonglioblastoma","volume":"6","author":"Gittleman","year":"2019","journal-title":"Neurooncol. Pract"},{"issue":"49","key":"2023100419475443800_CIT0069","first-page":"198","article-title":"Evaluation of North American Association of Central Cancer Registries\u2019 (NAACCR) data for use in population-based cancer survival studies","volume":"2014","author":"Weir","year":"2014","journal-title":"Journal of the National Cancer Institute: Monographs"},{"issue":"2","key":"2023100419475443800_CIT0070","first-page":"65","article-title":"Coding completeness and quality of relative survival-related variables in the National Program of Cancer Registries Cancer Surveillance System, 1995-2008","volume":"41","author":"Wilson","year":"2014","journal-title":"J. Registry. Manag"},{"issue":"3","key":"2023100419475443800_CIT0071","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1750-3639.1993.tb00752.x","article-title":"The new WHO classification of brain tumours","volume":"3","author":"Kleihues","year":"1993","journal-title":"Brain Pathol"},{"issue":"8","key":"2023100419475443800_CIT0072","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO Classification of Tumors of the Central Nervous System: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"3","key":"2023100419475443800_CIT0073","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00401-010-0725-7","article-title":"Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician\u2019s perspective","volume":"120","author":"van den Bent","year":"2010","journal-title":"Acta Neuropathol"},{"issue":"10","key":"2023100419475443800_CIT0074","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1002\/(SICI)1097-0142(20000515)88:10<2342::AID-CNCR19>3.0.CO;2-X","article-title":"Discrepancies in diagnoses of neuroepithelial neoplasms: the San Francisco Bay Area Adult Glioma Study","volume":"88","author":"Aldape","year":"2000","journal-title":"Cancer"},{"key":"2023100419475443800_CIT0075","year":"2008"},{"key":"2023100419475443800_CIT0076","article-title":"Data Comparability and Quality","volume-title":"Cancer Incidence in Five Continents, Vol. XI","author":"Bray","year":"2017"},{"issue":"4","key":"2023100419475443800_CIT0077","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/cncr.27405","article-title":"Predicting US- and state-level cancer counts for the current calendar year: Part II: evaluation of spatiotemporal projection methods for incidence","volume":"118","author":"Zhu","year":"2012","journal-title":"Cancer"},{"issue":"3","key":"2023100419475443800_CIT0078","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat. Med"},{"issue":"9","key":"2023100419475443800_CIT0079","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1002\/cncr.28509","article-title":"Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer","volume":"120","author":"Edwards","year":"2014","journal-title":"Cancer"},{"issue":"6","key":"2023100419475443800_CIT0080","doi-asserted-by":"crossref","first-page":"693","DOI":"10.7205\/MILMED-D-11-00434","article-title":"Cancer incidence among patients of the U.S. Veterans Affairs Health Care System","volume":"177","author":"Zullig","year":"2012","journal-title":"Mil. Med"},{"key":"2023100419475443800_CIT0081","year":"2023"},{"key":"2023100419475443800_CIT0082","first-page":"1537","article-title":"Impact of reporting delay and reporting error on cancer incidence rates and trends","volume-title":"J. Natl. Cancer Inst","author":"Clegg","year":"2002"},{"key":"2023100419475443800_CIT0083","author":"Surveillance Epidemiology and End Results (SEER) Program","year":"2020"},{"issue":"4","key":"2023100419475443800_CIT0084","first-page":"187","article-title":"Are Benign and Borderline Brain Tumors Underreported","volume":"43","author":"Li","year":"2016","journal-title":"J. Registry. Manag"},{"key":"2023100419475443800_CIT0085","volume-title":"Report of the Second Workshop on Age Adjustment","author":"Anderson","year":"1998"},{"issue":"3","key":"2023100419475443800_CIT0086","first-page":"1","article-title":"Age standardization of death rates: implementation of the year 2000 standard","volume":"47","author":"Anderson","year":"1998","journal-title":"National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System"},{"key":"2023100419475443800_CIT0087","author":"L.","year":"2018"},{"key":"2023100419475443800_CIT0088","volume-title":"The 2007 Multiple Primary and Histology Coding Rules.","author":"Johnson","year":"2007"},{"issue":"5","key":"2023100419475443800_CIT0089","first-page":"330","article-title":"Cancer collection efforts in the United States provide clinically relevant data on all primary brain and other CNS tumors","volume":"6","author":"Kruchko","year":"2019","journal-title":"Neurooncol. Pract"}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/Supplement_4\/iv1\/51862844\/noad149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/25\/Supplement_4\/iv1\/51862844\/noad149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T15:49:47Z","timestamp":1696434587000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/25\/Supplement_4\/iv1\/7289107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,4]]},"references-count":89,"journal-issue":{"issue":"Supplement_4","published-online":{"date-parts":[[2023,10,4]]},"published-print":{"date-parts":[[2023,10,4]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noad149","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,10,4]]},"published":{"date-parts":[[2023,10,4]]}}}